Prudential Financial’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4K | Sell |
596
-1,865
| -76% | -$13.8K | ﹤0.01% | 2424 |
|
|
2025
Q1 | $21.2K | Buy |
+2,461
| New | +$21.2K | ﹤0.01% | 2252 |
|
|
2024
Q3 | – | Sell |
-693
| Closed | -$34.8K | – | 2768 |
|
|
2024
Q2 | $34.8K | Hold |
693
| – | – | ﹤0.01% | 2648 |
|
|
2024
Q1 | $77.7K | Buy |
+693
| New | +$77.7K | ﹤0.01% | 2552 |
|
|
2023
Q2 | – | Sell |
-2,046
| Closed | -$210K | – | 2670 |
|
|
2023
Q1 | $210K | Sell |
2,046
-302
| -13% | -$31K | ﹤0.01% | 2387 |
|
|
2022
Q4 | $344K | Sell |
2,348
-1,762
| -43% | -$258K | ﹤0.01% | 2195 |
|
|
2022
Q3 | $694K | Buy |
4,110
+2,522
| +159% | +$426K | ﹤0.01% | 1923 |
|
|
2022
Q2 | $183K | Buy |
+1,588
| New | +$183K | ﹤0.01% | 2480 |
|
|
2020
Q1 | – | Sell |
-408
| Closed | -$58K | – | 2411 |
|
|
2019
Q4 | $58K | Buy |
+408
| New | +$58K | ﹤0.01% | 2394 |
|